Suboptimal outcomes and treatment burden of anti-vascular endothelial growth factor treatment for diabetic macular oedema in phakic patients

被引：0
|
作者：
Christina Rennie
Andrew Lotery
Jo Payne
Moushmi Singh
Faruque Ghanchi
机构：
[1] University Hospital Southampton NHS Foundation Trust,
[2] Faculty of Medicine,undefined
[3] University of Southampton,undefined
[4] AbbVie Ltd,undefined
[5] AbbVie House,undefined
[6] Vanwall Business Park,undefined
[7] Bradford Teaching Hospitals NHS Foundation Trust,undefined
来源：
Eye | 2024年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：215 / 223
页数：8
相关论文
共 50 条
  • [21] Visual Outcomes Based on Early Response to Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema
    Koyanagi, Yoshito
    Yoshida, Shigeo
    Kobayashi, Yoshiyuki
    Kubo, Yuki
    Nakama, Takahito
    Ishikawa, Keijiro
    Nakao, Shintaro
    Hisatomi, Toshio
    Ikeda, Yasuhiro
    Oshima, Yuji
    Ishibashi, Tatsuro
    Sonoda, Koh-hei
    OPHTHALMOLOGICA, 2018, 239 (2-3) : 94 - 102
  • [22] Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis
    Virgili, Gianni
    Curran, Katie
    Lucenteforte, Ersilia
    Peto, Tunde
    Parravano, Mariacristina
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (06):
  • [23] Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis
    Virgili, Gianni
    Parravano, Mariacristina
    Evans, Jennifer R.
    Gordon, Iris
    Lucenteforte, Ersilia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (10):
  • [24] Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis
    Virgili, Gianni
    Parravano, Mariacristina
    Evans, Jennifer R.
    Gordon, Iris
    Lucenteforte, Ersilia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (06):
  • [25] Treatment patterns and persistence rates with anti-vascular endothelial growth factor treatment for diabetic macular oedema in the UK: A real-world study
    Peto, Tunde
    Akerele, Toks
    Sagkriotis, Alexandros
    Zappacosta, Sofia
    Clemens, Andreas
    Chakravarthy, Usha
    DIABETIC MEDICINE, 2022, 39 (04)
  • [26] Microaneurysm density in residual oedema after anti-vascular endothelial growth factor therapy for diabetic macular oedema
    Yamada, Yutaka
    Takamura, Yoshihiro
    Morioka, Masakazu
    Gozawa, Makoto
    Matsumura, Takehiro
    Inatani, Masaru
    ACTA OPHTHALMOLOGICA, 2021, 99 (06) : E876 - E883
  • [27] The effect of intravitreal anti-vascular endothelial growth factor injections on corneal endothelium in patients with diabetic macular oedema
    Chatziralli, Irini
    Papadakou, Panagiota
    Dimitriou, Eleni
    Kazantzis, Dimitrios
    Kapsis, Petros
    Theodossiadis, George
    Papathanassiou, Miltiadis
    Theodossiadis, Panagiotis
    CUTANEOUS AND OCULAR TOXICOLOGY, 2021, 40 (02) : 66 - 69
  • [28] Anti-Vascular Endothelial Growth Factor Drug Treatment of Diabetic Macular Edema: The Evolution Continues
    Stewart, Michael W.
    CURRENT DIABETES REVIEWS, 2012, 8 (04) : 237 - 246
  • [29] How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema
    Singh, Rishi P.
    Tabano, David
    Kuo, Blanche L.
    Laprise, Andrew
    Leng, Theodore
    Kim, Eunice
    Hatfield, Meghan
    Garmo, Vincent
    BMC OPHTHALMOLOGY, 2024, 24 (01)
  • [30] Predictive factors for patients receiving intravitreal anti-vascular endothelial growth factor for the treatment of diabetic macular edema
    Carroll, Robert M.
    Yu, Yinxi
    VanderBeek, Brian L.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (01) : 72 - 80
12345